DexCom Is Up 90% Since January; Time To Sell?

Can Texas Instruments Stock Drop To $54?
May 14, 2020
After Allergan Acquisition Is AbbVie A Better Buy Compared To Merck?
May 14, 2020

DexCom Is Up 90% Since January; Time To Sell?

DexCom a company best known for its continuous glucose monitoring system, has seen its stock outperform year-to-date, rising by almost 90%, compared to the broader S&P which is down ~10%. The company has been witnessing higher demand for its glucose monitoring devices…
Source: Forbes Markets

Comments are closed.